WallStreetZenWallStreetZen

NASDAQ: MGX
Metagenomi Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

MGX past revenue growth

How has MGX's revenue growth performed historically?
Company
160.21%
Industry
143.99%
Market
17.8%
MGX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
MGX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
MGX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

MGX earnings and revenue history

Current Revenue
$44.8M
Current Earnings
-$68.3M
Current Profit Margin
-152.5%

MGX Return on Equity

Insufficient data to display

Be the first to know when MGX announces earnings.

MGX Return on Assets

Current Company
-17.5%
Current Industry
2.9%
MGX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

MGX Return on Capital Employed

Current Company
-20.35%
Current Industry
19.5%

MGX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
MGX$44.76M-$51.81M-$68.26M+1,257.13%N/A
PSTX$64.70M-$109.04M-$123.43M+43.92%N/A
AKBA$194.62M-$4.05M-$51.93M-1.30%N/A
FBLG$0.00-$15.90M-$19.06MN/AN/A
HOWL$19.94M-$30.89M-$37.37M+21.60%N/A
View Top Biotech Stocks

Metagenomi Earnings & Revenue FAQ

What were MGX's earnings last quarter?

Metagenomi (NASDAQ: MGX) reported Q4 2023 earnings per share (EPS) of -$5.67, up 31.86% year over year. Total Metagenomi earnings for the quarter were -$19.29 million. In the same quarter last year, Metagenomi's earnings per share (EPS) was -$4.30.

If you're new to stock investing, here's how to buy Metagenomi stock.

What was MGX's earnings growth in the past year?

As of Q2 2024, Metagenomi's earnings has grown year over year. Metagenomi's earnings in the past year totalled -$68.26 million.

What was MGX's revenue last quarter?

Metagenomi (NASDAQ: MGX) reported Q4 2023 revenue of $12.40 million up 121.61% year over year. In the same quarter last year, Metagenomi's revenue was $5.60 million.

What was MGX's revenue growth in the past year?

As of Q2 2024, Metagenomi's revenue has grown 160.21% year over year. This is 16.22 percentage points higher than the US Biotechnology industry revenue growth rate of 143.99%. Metagenomi's revenue in the past year totalled $44.76 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.